Medical Devices: Technologies and Global Markets

Medical Devices: Technologies and Global Markets

  • January 2017
  • 316 pages
  • BCC Research
Report ID: 2374321

Use this report to:
- Understand key market dynamics and the factors impacting the global medical device technologies market, including segments and subsegments.
- Assess market revenues of the global medical device technology industry by segment, region and products.
- Identify market trends, issues and factors impacting medical device technologies.
- Gain insight into major players and their corporate profile, analyzing their market shares, core competencies and strategies in the medical device technology market.


Highlights
- The global market for medical device technologies reached $458.3 billion in 2015. The market should reach $483.5 billion in 2016 and $634.5 billion by 2021, growing at a compound annual growth rate (CAGR) of 5.6% from 2016 to 2021.
- The North America market for medical device technologies reached $168.1 billion in 2015. The market should reach $175.6 billion in 2016 and $216.1 billion by 2021, growing at a CAGR of 4.2% from 2016 to 2021.
- The Asia-Pacific market for medical device technologies reached $101.3 billion in 2015. The market should reach $108.9 billion in 2016 and $156.6 billion by 2021, growing at a CAGR of 7.1% from 2016 to 2021.


INTRODUCTION
This report discusses the medical device technology industry in terms of major players’ market shares, market growth and size, and opportunities for different devices and regions. The report includes forecasts for market trends and revenue through 2021. Major players, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed.



STUDY GOALS AND OBJECTIVES

The goals and objectives of the study include:
- Defining and discussing the global medical device technologies market.
- Analyzing market structure, including segments and subsegments.
- Estimating market revenues of the global medical device technology industry by segment, region and products.
- Identifying market trends, issues and factors impacting medical device technologies.
- Studying various submarkets with respect to growth drivers and inhibitors of the medical device technology market.
- Explaining opportunities in the medical device technology market with respect to region and products.
- Profiling major players and analyzing their market shares, core competencies and strategies in the medical device technology market.
- Tracking alliances, joint ventures, mergers and acquisitions, new product developments, and research and development in the global medical device technology market.

MARKET DESCRIPTION
A medical device is an instrument, apparatus, implant, in vitro reagent or similar device used to diagnose, prevent or treat disease or other conditions. Several medical device technologies enhance the functions of medical devices, including highly sophisticated scanners and technologically complicated implantable products, such as artificial cochlear devices, as well as the most basic laboratory equipment.

According to estimates, there are more than 500,000 medical technologies currently available in roughly 20,000 generic groups. According to the World Health Organization (WHO), there are an estimated 1.5 million different medical devices, in more than 10,000 types of generic device groups available globally. The Global Medical Devices Nomenclature (GMDN) Agency has classified these into 16 product categories. The primary aim of any medical technology is to improve medical care, making it easier to improve the overall health of users or patients. With life spans increasing over the last few decades, the importance of better care and improved quality of life has become paramount.


SCOPE OF THE REPORT
This research report incorporates an in-depth analysis of the medical device technology market, including market estimations and trends through 2018. Major players, competitive intelligence, innovative technologies, market dynamics and regional opportunities are discussed in detail. The report also examines recent developments and product portfolios of the major players, along with their market shares. Patent analysis focuses on technological trends in recent years in regions such as the U.S., Europe and Japan. The report presents a market analysis and estimates the compound annual growth rate (CAGR) for medical device technologies.

The scope of the report extends to only those medical device technologies that generate the most global revenue. Dental device technologies and some imaging devices used in dentistry overlap with other devices already covered under the imaging device technologies segments, so they have been excluded.



INTENDED AUDIENCE

- Individuals and groups who would benefit from the content of this report include:
- Medical device manufacturers and new entrants.
- Equipment distributors, hospitals and other healthcare service providers.
- Various life sciences companies.
- Research institutes, associations and academicians.



RESEARCH METHODOLOGY
A top-down approach was taken to estimate the market size of medical device technologies. Revenues from the medical device technology market were determined through primary and secondary research, including a study of the annual reports of listed market players. Secondary research was carried out with a general search of keywords through paid sources such as Factiva and One Source, and other publicly available websites, including company websites. Estimation of micro-markets was done through primary and secondary sources, and then validated through primary sources. Forecasts were based on the analysis of market trends, market dynamics and strategies of key players. Regional estimates were determined by using secondary sources verified through primary sources.


ANALYST'S CREDENTIALS
Vijay Laxmi has more than 20 years of experience in the healthcare domain. In addition to business research and consulting, she has conducted corporate briefings for top players in a wide range of market segments. She has worked with major market research firms and handled projects for various consultancies. Her market research studies include reports on:
- Various medical device markets.
- High-growth and niche markets in healthcare and life sciences.
- Home healthcare market.
- Medical tourism.
CHAPTER 1
INTRODUCTION 2
STUDY GOALS AND OBJECTIVES 2
MARKET DESCRIPTION 2
SCOPE OF THE REPORT 3
INTENDED AUDIENCE 3
RESEARCH METHODOLOGY 3
ANALYST'S CREDENTIALS 3
RELATED BCC RESEARCH REPORTS 4
BCC RESEARCH WEBSITE 4
DISCLAIMER 5
CHAPTER 2 EXECUTIVE SUMMARY 7
SUMMARY TABLE GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 7
SUMMARY FIGURE GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, 2015-2021 ($ MILLIONS) 7
CHAPTER 3 MARKET OVERVIEW 10
INNOVATIONS IN THE MEDICAL DEVICE TECHNOLOGY INDUSTRY 11
CURRENT TRENDS IN THE MEDICAL DEVICE TECHNOLOGY INDUSTRY 11
DEFINITION, EVOLUTION AND TYPES OF MEDICAL TECHNOLOGIES 12
DEFINITION 13
EVOLUTION 13
TYPES 16
Imaging Systems 16
In vitro Diagnostics 17
Cardiovascular Disease Procedures 17
Orthopedic and Spinal Procedures 17
REGULATIONS AND LEGISLATIONS 18
EUROPE 18
Restriction of Hazardous Substances II 19
U.S. 19
CHINA 21
JAPAN 22
INDIA 24
OTHERS 24
Indonesia 24
South Korea 25
Malaysia 26
Philippines 26
Singapore 27
Taiwan 28
Australia 29
Hong Kong 29
Vietnam 29
MARKET DYNAMICS 29
DRIVERS 29
Aging Global Population 29
FIGURE 1 GLOBAL POPULATION OLDER THAN AGE 60 BY REGION, 2013 30
Increase in Lifestyle and Chronic Diseases 31
FIGURE 2 GLOBAL PROJECTED GROWTH OF DIABETES INCIDENCES IN PATIENTS AGE 20-79, 2010 AND 2030 (%) 32
Molecular Medicine and Minimally Invasive Techniques 32
Other Drivers 33
RESTRAINTS 33
OPPORTUNITIES 34
STRATEGIES 35
DISTRIBUTION NETWORK 36
ASIA-PACIFIC 36
U.S. 36
EUROPE 37
INDIA 38
CHINA 38
OTHERS 40
Japan 40
South Korea 41
TRENDS 42
CHINA 42
EUROPE 42
NEW PRODUCTS AND TECHNOLOGIES 43
NEW MATERIALS 43
REFURBISHED AND REPLACEMENT MARKET 44
MERGERS AND ACQUISITIONS 46
RECOMMENDATIONS 48
CHAPTER 4 GLOBAL MEDICAL DEVICE TECHNOLOGY MARKET 51
OVERVIEW 51
TABLE 1 GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGY BY SEGMENT, THROUGH 2021 ($ MILLIONS) 51
IMAGING DEVICES 51
TABLE 2 GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 52
MARKET DYNAMICS 52
Increased Life Expectancy 53
Growing Incidence of Diseases 53
Improvement in Medical Device Technologies 53
Legislative Amendments and Other Initiatives 53
Resistance to New Technology-Based Systems Due to High Costs 54
Excise Duties Levied Under the Patient Protection and Affordable Care Act 54
Large Population Base in Emerging Economies 54
Increasing Government Spending on Healthcare and Healthcare Infrastructure 54
TABLE 3 GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 55
MAGNETIC IMAGING RESONANCE 55
Market Dynamics 56
FIGURE 3 GLOBAL INCIDENCE OF PATIENTS WITH CHRONIC DISEASES, 2005-2030 (MILLIONS) 56
TABLE 4 GLOBAL MARKET FOR MAGNETIC IMAGING RESONANCE TECHNOLOGY BY REGION,THROUGH 2021 ($ MILLIONS) 58
Innovation and New Products 58
GE Healthcare 58
Toshiba 59
Siemens 60
Hitachi 61
Philips 61
Trends 62
FIGURE 4 GLOBAL MARKET SHARES OF KEY COMPANIES IN MAGNETIC IMAGING RESONANCE TECHNOLOGIES, 2015 (%) 62
ULTRASOUND TECHNOLOGY MARKET 63
Market Dynamics 64
FIGURE 5 COUNTRIES WITH THE HIGHEST PERCENTAGE OF PEOPLE AGE 60 AND OLDER, 2011 64
FIGURE 6 COUNTRIES WITH THE HIGHEST EXPECTED PERCENTAGE OF PEOPLE AGE 60 AND OLDER, 2050 65
New Product Innovations 66
Market Trends 68
TABLE 5 GLOBAL MARKET FOR ULTRASOUND TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 70
FIGURE 7 GLOBAL MARKET SHARES OF ULTRASOUND TECHNOLOGIES BY COMPANY, 2015 (%) 70
LASER IMAGING MARKET 71
TABLE 6 GLOBAL MARKET FOR LASER IMAGING DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 72
Market Dynamics 72
FIGURE 8 GLOBAL PREVALENCE OF ALZHEIMER'S DISEASE BY REGION, 2010-2050 72
New Product Innovations 74
Market Trends 75
FIGURE 9 GLOBAL MARKET SHARES FOR LASER IMAGING BY COMPANY, 2015 (%) 75 INTERVENTIONAL RADIOLOGY MARKET 76
TABLE 7 GLOBAL MARKET FOR INTERVENTIONAL RADIOLOGY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 77
Market Dynamics 77
FIGURE 10 GLOBAL ANGIOPLASTY PROCEDURES, 2009-2012 78
FIGURE 11 GLOBAL STENTS USED IN CORONARY PROCEDURES, 2009-2012 (NO. OF STENTS) 79
Innovation and New Products 80
Market Trends 81
X-RAY 82
TABLE 8 GLOBAL MARKET FOR X-RAY DEVICE TECHNOLOGIES BY REGION,
THROUGH 2021 ($ MILLIONS) 82
Market Dynamics 82
FIGURE 12 PICTURE ARCHIVING AND COMMUNICATION SYSTEM PROCESS FOR OBTAINING IMAGES 83
FIGURE 13 GLOBAL POPULATION BY AGE GROUP, 2000 AND 2050 (%) 84
TABLE 9 TARGET DISEASE STATISTICS 85
Innovation and New Products 85
Market Trends 86
FIGURE 14 GLOBAL MARKET SHARES FOR X-RAY SYSTEMS BY COMPANY, 2015 (%) 88
COMPUTER TOMOGRAPHY 88
TABLE 10 GLOBAL MARKET FOR COMPUTER TOMOGRAPHY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 89
Market Dynamics 89
FIGURE 15 CORONARY HEART DISEASE IN SELECTED COUNTRIES, 2012 (%) 90
Innovation and New Products 91
GE Healthcare 91
Phillips 92
NUCLEAR MEDICINE AND POSITRON EMISSION TOMOGRAPHY (PET) 93
TABLE 11 GLOBAL MARKET FOR NUCLEAR MEDICINE/PET TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 93
Market Dynamics 93
FIGURE 16 GLOBAL CARDIOVASCULAR MORTALITY BY INCOME LEVEL, 2011 (%) 94
Innovation and New Products 95
Market Trends 96
TABLE 12 GLOBAL MARKET FOR POINT-OF-CARE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 99
Market Share of Key Players 99
POINT-OF-CARE TECHNOLOGIES 99
TABLE 13 GLOBAL MARKET FOR POINT-OF-CARE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 100
Market Dynamics 100
Innovation and New Products 101
Market Trends 102
Market Share of Key Players 102
IN VITRO DIAGNOSTIC DEVICES 102
TABLE 14 GLOBAL MARKET FOR IN VITRO DIAGNOSTIC TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 104
MARKET DYNAMICS 104
FIGURE 17 HEALTHCARE EXPENDITURES IN THE U.S., CHINA AND INDIA, 2009-2011 105
Overall In Vitro Diagnostics Market Share 107
FIGURE 18 GLOBAL MARKET SHARES FORIN VITRO DIAGNOSTICS BY COMPANY, 2015 (%) 107
Professional In Vitro Diagnostics Market Share 109
FIGURE 19 GLOBAL MARKET SHARES FOR PROFESSIONAL DIAGNOSTICS BY COMPANY, 2015 (%) 109
In Vitro Diagnosis Types 110
Immunoassays 110
Diabetes Testing 110
Blood Testing and Hematology 111
Molecular Diagnosis 111
TABLE 15 GLOBAL MARKET FOR IN VITRO DIAGNOSTIC TECHNOLOGIES BY SEGMENTS, THROUGH 2021 ($ MILLIONS) 112
REGULATIONS 112
IN VITRO DIAGNOSTICS MARKET BY REGION 114
IMMUNOCHEMISTRY 114
TABLE 16 GLOBAL MARKET FOR IMMUNOCHEMISTRY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 115
MARKET DYNAMICS 115
FIGURE 20 CARDIOVASCULAR DISEASE IN SELECTED REGIONS, 2012 (%) 116
FIGURE 21 NEW GLOBAL HIV INFECTIONS BY REGION, 2012 (NO.) 117
INNOVATION AND NEW PRODUCTS 118
TRENDS 119
MARKET SHARE OF KEY PLAYERS 120
FIGURE 22 GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR INFECTIOUS DISEASES, 2015 (%) 120
FIGURE 23 GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR HEPATITIS AND RETROVIRUS, 2015 (%) 121
FIGURE 24 GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR ONCOLOGY AND ENDOCRINOLOGY, 2015 (%) 122
FIGURE 25 GLOBAL MARKET SHARES FOR IMMUNOASSAY FOR NUCLEIC ACID TESTING, 2015 123
TABLE 17 GLOBAL MARKET FOR CLINICAL CHEMISTRY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 124
POINT-OF-CARE DIAGNOSTIC MARKET 124
TABLE 18 POINT-OF-CARE DIAGNOSTIC TESTS AND MANUFACTURERS 125
TABLE 19 DIABETES INCIDENCE IN THE TOP 10 COUNTRIES, 2013 (THOUSANDS) 126
FIGURE 26 GLOBAL PREVALENCE OF DIABETES BY AGE GROUP BY REGION, 2013 (THOUSANDS) 126
FIGURE 27 SHIFT IN USAGE OF POINT-OF-CARE DIAGNOSTIC SOLUTIONS 127
TABLE 20 GLOBAL MARKET FOR POINT-OF-CARE TESTING TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 128
INNOVATION AND NEW PRODUCTS 129
TRENDS 129
FIGURE 28 U.S. HOSPITAL HEALTHCARE SPENDING, 2010-2012 ($ BILLIONS) 129
TABLE 21 POINT-OF-CARE DIAGNOSTIC SOLUTIONS ACROSS PRODUCT SEGMENTS 130
COMPETITIVE LANDSCAPE 130
FIGURE 29 GLOBAL MARKET SHARES FOR POINT-OF-CARE DIAGNOSTICS BY COMPANY, 2015 (%) 131
MOLECULAR DIAGNOSTICS 132
TABLE 22 GLOBAL MARKET FOR MOLECULAR DIAGNOSTIC TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 132
GROWING GLOBAL PREVALENCE OF HOSPITAL-ACQUIRED AND HPV INFECTIONS 132
FIGURE 30 APPLICATION OF MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE SEGMENTS, 2015 (%) 132
PHARMACOGENOMICS 133
POINT-OF-CARE TESTING 134
MARKET TRENDS 134
U.S. 134
China 134
India 135
Overall Market Trends 135
COMPETITIVE LANDSCAPE 135
FIGURE 31 GLOBAL MARKET SHARES FOR MOLECULAR DIAGNOSTICS BY COMPANY, 2015 (%) 135
BLOOD TESTING 136
TABLE 23 GLOBAL MARKET FOR HEMATOLOGY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 138
MARKET TRENDS 138
U.S. 138
China 138
COMPETITIVE LANDSCAPE 139
CARDIOVASCULAR DEVICE MARKET 139
TABLE 24 GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 139
CARDIOVASCULAR DISEASE TYPES 140
Cardiac Arrhythmia 140
TABLE 25 ABLATION TYPES AND THEIR MECHANISMS 141
Coronary Blockages 141
TABLE 26 GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 142
MARKET DYNAMICS 142
FIGURE 32 GLOBAL POPULATION BY AGE GROUP, 2000 AND 2050 (%) 142
INTERVENTIONAL CARDIOLOGY DEVICES 144
Stents 144
FIGURE 33 EVOLUTION OF CORONARY STENTS 144
TABLE 27 INCIDENCE OF RESTENOSIS BY STENT TYPE, 2014 (%) 144
TABLE 28 DRUG-ELUTING STENT PRODUCTS AND MANUFACTURERS 145
TABLE 29 BIO-ABSORBABLE STENT PRODUCTS AND MANUFACTURERS 145
Percutaneous Transluminal Coronary Angioplasty Balloons 146
TABLE 30 COMPARATIVE ANALYSIS OF STENTS BY BALLOON PLATFORM 146
Percutaneous Transluminal Coronary Angioplasty Guidewires 147
Percutaneous Transluminal Coronary Angioplasty Guiding Catheters 147
Angiography Catheters 147
Balloon Inflation Devices 148
TABLE 31 MANUFACTURERS AND THEIR PRODUCTS 148
Intravascular Ultrasound 148
Cardiovascular Device Market Trends 149
REGULATIONS 150
CARDIAC RHYTHM MANAGEMENT MARKET 150
TABLE 32 GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 151
Market Dynamics 152
FIGURE 34 GLOBAL POPULATION BASE TO AGE 65 AND OLDER, 2000 AND 2050 (%) 152
Market Trends 153
Pharmacological Treatment 154
TABLE 33 ANTI-ARRHYTHMIC DRUG TYPES AND CLINICAL USAGE 154
TABLE 34 ANTI-ARRHYTHMIC DRUG CLASSIFICATION AND CLINICAL USAGE 154
Non-Pharmacological Treatment 156
Maze Surgery Procedures 157
Electric Cardioversion Procedures 158
Global Market Trends 158
Competitive Rivalry 159
CARDIAC CATHETERIZATION TECHNOLOGIES 160
TABLE 35 GLOBAL MARKET FOR CARDIAC CATHETERIZATION TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 160
Market Dynamics 161
Innovation and New Products 163
ORTHOPEDIC AND SPINAL TECHNOLOGIES 164
TABLE 36 GLOBAL MARKET FOR ORTHOPEDIC AND SPINAL TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 164
MARKET DYNAMICS 164
REGION 165
TABLE 37 GLOBAL MARKET FOR ORTHOPEDIC AND SPINE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 165
REGULATIONS 166
RECONSTRUCTIVE IMPLANTS 166
TABLE 38 GLOBAL MARKET FOR RECONSTRUCTIVE IMPLANT TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 166
Market Dynamics 167
FIGURE 35 OSTEOPOROTIC HIP FRACTURES BY REGION, 1990 AND 2050 (THOUSANDS) 167
Innovation and New Products 169
Trends 171
Market Share 172
FIGURE 36 GLOBAL MARKET SHARES FOR RECONSTRUCTIVE IMPLANT TECHNOLOGIES BY COMPANY, 2015 (%) 172
SPINAL IMPLANTS 173
TABLE 39 GLOBAL MARKET FOR SPINE DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 174
Market Dynamics 174
Market Trends 175
TABLE 40 FDA AND CE APPROVALS OF SPINAL CORD STIMULATION DEVICES, 2001-2015 177
Innovation and New Products 177
Market Share Analysis 178
FIGURE 37 GLOBAL MARKET SHARES FOR SPINAL IMPLANT BY COMPANY, 2015 (%) 178
TRAUMA FIXATION DEVICE TECHNOLOGY MARKET 178
TABLE 41 GLOBAL MARKET FOR TRAUMA FIXATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 179
Market Dynamics 179
FIGURE 38 GLOBAL MARKET SHARES FOR TRAUMA DEVICE FIXATION BY COMPANY, 2015 180
Orthopedic Robotic Systems 180
TABLE 42 GLOBAL MARKET FOR ROBOTIC SYSTEM TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 181
Major Orthopedic Robotic Systems 182
MAKO RIO Surgical System 182
Stanmore Sculptor Robotic Guidance Arm 182
NavioPFS Surgical System 182
iBlock Surgical System 183
ROBODOC Surgical System 183
UROLOGY DEVICE MARKET 184
TABLE 43 GLOBAL MARKET FOR UROLOGY AND RENAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 184
MARKET DYNAMICS 185
TABLE 44 GLOBAL MARKET FOR UROLOGY AND RENAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 185
MEDICAL LASER SYSTEMS FOR UROLOGY 185
TABLE 45 GLOBAL MARKET FOR LITHOTRIPTER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 186
REGIONS 186
FIGURE 39 GLOBAL PREVALENCE OF KIDNEY DISEASE BY REGION, 2012 (%) 186
REGULATIONS 187
INCONTINENCE DEVICES 188
Market Dynamics 188
FIGURE 40 LIFE EXPECTANCY AT BIRTH FOR SELECTED COUNTRIES, 2012 (YEARS) 188
Trends 189
TABLE 46 GLOBAL MARKET FOR INCONTINENCE DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 190
FIGURE 41 GLOBAL POPULATION BASE AGE 60 AND OLDER, 2010-2017 (%) 190
Innovation and New Products 191
Market Shares 191
Ostomy Care Device Market 191
FIGURE 42 GLOBAL MARKET SHARES FOR OSTOMY CARE DEVICES BY COMPANY, 2015 (%) 191
Incontinence Care Device Market 192
FIGURE 43 GLOBAL MARKET SHARES FOR INCONTINENCE CARE DEVICES BY COMPANY, 2015 (%) 192
RENAL DIALYSIS DEVICE MARKET 193
TABLE 47 GLOBAL MARKET FOR RENAL DIALYSIS DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 193
FIGURE 44 GLOBAL MARKET SHARES FOR RENAL DIALYSIS DEVICES BY COMPANY, 2015 193
ENDOSCOPY DEVICES 194
TABLE 48 GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 195
TYPES 195
TABLE 49 GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 196
MARKET DYNAMICS 196
FIGURE 45 GLOBAL PREVALENCE OF COLON CANCER BY AGE, 2015 197
RIGID ENDOSCOPES 198
TABLE 50 GLOBAL MARKET FOR RIGID ENDOSCOPIC DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 198
Market Dynamics 199
FLEXIBLE ENDOSCOPES 200
TABLE 51 GLOBAL MARKET FOR FLEXIBLE ENDOSCOPIC DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 201
Market Dynamics 201
INNOVATION AND NEW PRODUCTS 202
DRUG DELIVERY DEVICES 202
TABLE 52 GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 203
TABLE 53 GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 203
MARKET DYNAMICS 203
Increasing Prevalence of Cardiovascular Disease 203
Increasing Global Prevalence of Prostate Cancer 204
Emergence of New Disease Applications for Cervical Cancer and Breast Cancer 204
Growing Global Elderly Population Base 204
Rising Prevalence of Diabetes and Diabetic Retinopathy 204
Growing Prevalence of Unwanted Pregnancies 204
Government and Nongovernmental Organization Initiatives to Promote Contraceptive Products 205
Introduction of New and Advanced Implantable Drug Delivery Devices 205
Introduction of Biodegradable Technology Products 206
Product Recalls, Lawsuits and the Introduction of Internal Product Substitutes 206
Stringent FDA and CE Approval Norms 207
INFUSION SYSTEMS 207
TABLE 54 GLOBAL MARKET FOR INFUSION SYSTEM AND INJECTABLE DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 207
Market Dynamics 208
Rising Global Prevalence of Colorectal Cancer 208
High Prevalence of Chronic Pain Causing Disorders 208
Innovation and New Products 208
Market Trends 209
INHALATION DEVICES 209
TABLE 55 GLOBAL MARKET FOR INHALATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 210
Market Dynamics 211
Innovation and New Products 211
Trends 211
NEEDLE-FREE INJECTIONS AND TRANSDERMAL SYSTEMS 213
TABLE 56 GLOBAL MARKET FOR NEEDLE-FREE INJECTION AND TRANSDERMAL SYSTEM TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 214
Market Dynamics 214
New Product Developments 215
Market Trends 215
TABLE 57 MAJOR DRUGS ADMINISTERED THROUGH TRANSDERMAL DRUG DELIVERY TECHNIQUES 216
CHAPTER 5 MEDICAL DEVICE TECHNOLOGIES MARKET BY REGION 219
NORTH AMERICA 219
TABLE 58 NORTH AMERICAN MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 219
EUROPE 219
TABLE 59 EUROPEAN MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 220
ASIA-PACIFIC 220
TABLE 60 ASIA-PACIFIC MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 221
CHINA 221
REST OF THE WORLD 222
TABLE 61 REST OF THE WORLD MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 223
CHAPTER 6 COMPETITIVE LANDSCAPE 225
TABLE 62 PRODUCT LAUNCHES AND APPROVALS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016 225
TABLE 63 MERGERS AND ACQUISITIONS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET, JANUARY 2013-SEPTEMBER 2016 233
TABLE 64 AGREEMENTS, JOINT VENTURES, EXPANSIONS, DIVESTMENTS AND INVESTMENTS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016 240
TABLE 65 CERTIFICATION, REORGANIZATION, RESEARCH AND DEVELOPMENT FACILITIES, AND SERVICES AND SOLUTIONS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016 248
TABLE 66 CERTIFICATIONS AND SERVICES IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016 256
TABLE 67 REORGANIZATION, COLLABORATION, SPINOFFS, RESEARCH AND DEVELOPMENT AND APPROVALS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016 257
CHAPTER 7 COMPANY PROFILES 260
3M 260
TABLE 68 3M PRODUCT PORTFOLIO 260
TABLE 69 3M DEVELOPMENTS, JANUARY 2013-APRIL 2016 261
ABBOTT LABORATORIES 261
TABLE 70 ABBOTT LABORATORIES PRODUCT PORTFOLIO 261
TABLE 71 ABBOTT LABORATORIES DEVELOPMENTS, JANUARY 2013-APRIL 2016 262
AGILENT TECHNOLOGIES 262
TABLE 72 AGILENT PRODUCT PORTFOLIO 262
TABLE 73 AGILENT DEVELOPMENTS, JANUARY 2013-APRIL 2016 263
BAYER 263
TABLE 74 BAYER HEALTHCARE PRODUCT PORTFOLIO 264
TABLE 75 BAYER HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016 264
BAXTER INTERNATIONAL 264
TABLE 76 BAXTER INTERNATIONAL PRODUCT PORTFOLIO 265
TABLE 77 BAXTER INTERNATIONAL DEVELOPMENTS, JANUARY 2013-APRIL 2016 265
BECKTON, DICKINSON AND CO. 266
TABLE 78 BECKTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO 266
TABLE 79 BECKTON, DICKINSON AND COMPANY DEVELOPMENTS, JANUARY 2013-APRIL 2016 266
BOSTON SCIENTIFIC 267
TABLE 80 BOSTON SCIENTIFIC PRODUCT PORTFOLIO 268
TABLE 81 BOSTON SCIENTIFIC DEVELOPMENTS, JANUARY 2013-APRIL 2016 268
CARDINAL HEALTH 269
TABLE 82 CARDINAL HEALTH PRODUCT PORTFOLIO 269
TABLE 83 CARDINAL HEALTH DEVELOPMENTS, JANUARY 2013-APRIL 2016 270
COVIDIEN 270
TABLE 84 COVIDIEN PRODUCT PORTFOLIO 271
TABLE 85 COVIDIEN DEVELOPMENTS, JANUARY 2013-APRIL 2016 271
DANAHER 272
TABLE 86 DANAHER PRODUCT PORTFOLIO 272
TABLE 87 DANAHER DEVELOPMENTS, JANUARY 2013-APRIL 2016 273
DRAGER 273
TABLE 88 DRÄGER PRODUCT PORTFOLIO 274
TABLE 89 DRÄGER DEVELOPMENTS, JANUARY 2013-APRIL 2016 274
FRESENIUS 275
TABLE 90 FRESENIUS PRODUCT PORTFOLIO 275
TABLE 91 FRESENIUS DEVELOPMENTS, JANUARY 2013-APRIL 2016 276
GE HEALTHCARE 276
TABLE 92 GE HEALTHCARE PRODUCT PORTFOLIO 277
TABLE 93 GE HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016 277
GETINGE AB 279
TABLE 94 GETINGE AB PRODUCT PORTFOLIO 280
TABLE 95 GETINGE AB DEVELOPMENTS, JANUARY 2013-APRIL 2016 280
HALYARD HEALTH, INC. 280
TABLE 96 HALYARD HEALTH, INC. PRODUCT PORTFOLIO 281
TABLE 97 KIMBERLY-CLARK HEALTHCARE DEVELOPMENTS, JANUARY 2013-SEPTEMBER 2016 281
HOSPIRA 282
TABLE 98 HOSPIRA PRODUCT PORTFOLIO 282
TABLE 99 HOSPIRA DEVELOPMENTS, JANUARY 2013-APRIL 2016 283
JOHNSON & JOHNSON 283
TABLE 100 JOHNSON & JOHNSON PRODUCT PORTFOLIO 283
TABLE 101 JOHNSON & JOHNSON DEVELOPMENTS, JANUARY 2013-APRIL 2016 284
MEDTRONIC 285
TABLE 102 MEDTRONIC PRODUCT PORTFOLIO 286
TABLE 103 MEDTRONIC RECENT DEVELOPMENTS, JANUARY 2013-APRIL 2016 286
NOVARTIS 287
TABLE 104 NOVARTIS PRODUCT PORTFOLIO 288
TABLE 105 NOVARTIS DEVELOPMENTS, JANUARY 2013-APRIL 2016 288
OLYMPUS CORPORATION 288
TABLE 106 OLYMPUS CORP. PRODUCT PORTFOLIO 289
TABLE 107 OLYMPUS CORP. DEVELOPMENTS, JANUARY 2013-APRIL 2016 290
PALL CORP. 290
TABLE 108 PALL CORP. PRODUCT PORTFOLIO 291
TABLE 109 PALL CORP. DEVELOPMENTS, JANUARY 2013-APRIL 2016 291
PHILIPS HEALTHCARE 291
TABLE 110 PHILIPS PRODUCT PORTFOLIO 292
TABLE 111 PHILIPS DEVELOPMENTS, JANUARY 2013-APRIL 2016 293
ROCHE DIAGNOSTICS 294
TABLE 112 ROCHE DIAGNOSTICS PRODUCT PORTFOLIO 294
TABLE 113 ROCHE DIAGNOSTICS DEVELOPMENTS, JANUARY 2013-APRIL 2016 295
SAINT JUDE MEDICAL 295
TABLE 114 SAINT JUDE MEDICAL PRODUCT PORTFOLIO 296
TABLE 115 SAINT JUDE MEDICAL DEVELOPMENTS, JANUARY 2013-APRIL 2016 296
SIEMENS HEALTHCARE 297
TABLE 116 SIEMENS HEALTHCARE PRODUCT PORTFOLIO 297
TABLE 117 SIEMENS HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016 297
SMITH & NEPHEW 298
TABLE 118 SMITH & NEPHEW PRODUCT PORTFOLIO 299
TABLE 119 SMITH & NEPHEW DEVELOPMENTS, JANUARY 2013-APRIL 2016 299
SMITHS MEDICAL 300
TABLE 120 SMITHS MEDICAL PRODUCT PORTFOLIO 300
TABLE 121 SMITHS MEDICAL DEVELOPMENTS, JANUARY 2013-APRIL 2016 301
STRYKER CORP. 302
TABLE 122 STRYKER CORP. PRODUCT PORTFOLIO 302
TABLE 123 STRYKER CORP. DEVELOPMENTS, 2013-APRIL 2016 303
SYNTHES 304
TABLE 124 SYNTHES PRODUCT PORTFOLIO 304
TELEFLEX 304
TABLE 125 TELEFLEX PRODUCT PORTFOLIO 305
TABLE 126 TELEFLEX DEVELOPMENTS, JANUARY 2013-APRIL 2016 305
THERMO FISHER SCIENTIFIC 306
TABLE 127 THERMO FISHER SCIENTIFIC PRODUCT PORTFOLIO 307
TABLE 128 THERMO FISHER SCIENTIFIC DEVELOPMENTS, JANUARY 2013-APRIL 2016 307
TOSHIBA MEDICAL SYSTEMS CORP. 308
TABLE 129 TOSHIBA MEDICAL SYSTEMS PRODUCT PORTFOLIO 309
TABLE 130 TOSHIBA MEDICAL SYSTEMS DEVELOPMENTS, JANUARY 2013-APRIL 2016 309
ZIMMER HOLDINGS 310
TABLE 131 ZIMMER HOLDINGS PRODUCT PORTFOLIO 310
TABLE 132 ZIMMER HOLDINGS DEVELOPMENTS, JANUARY 2013-FEBRUARY 2016 310
CHAPTER 8 PATENT ANALYSIS 313
TABLE 133 U.S. MEDICAL DEVICE TECHNOLOGY PATENTS, 2011-APRIL 2016 313
TABLE 134 EUROPEAN MEDICAL DEVICE TECHNOLGY PATENTS, 2011-APRIL 2016 316
TABLE 135 JAPANESE MEDICAL DEVICE TECHNOLOGY PATENTS, 2011-APRIL 2016 322



LIST OF TABLES
SUMMARY TABLE GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 7
TABLE 1 GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGY BY SEGMENT, THROUGH 2021 ($ MILLIONS) 51
TABLE 2 GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 52
TABLE 3 GLOBAL MARKET FOR IMAGING DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 55
TABLE 4 GLOBAL MARKET FOR MAGNETIC IMAGING RESONANCE TECHNOLOGY BY REGION,THROUGH 2021 ($ MILLIONS) 58
TABLE 5 GLOBAL MARKET FOR ULTRASOUND TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 70
TABLE 6 GLOBAL MARKET FOR LASER IMAGING DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 72
TABLE 7 GLOBAL MARKET FOR INTERVENTIONAL RADIOLOGY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 77
TABLE 8 GLOBAL MARKET FOR X-RAY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 82
TABLE 9 TARGET DISEASE STATISTICS 85
TABLE 10 GLOBAL MARKET FOR COMPUTER TOMOGRAPHY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 89
TABLE 11 GLOBAL MARKET FOR NUCLEAR MEDICINE/PET TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 93
TABLE 12 GLOBAL MARKET FOR POINT-OF-CARE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 99
TABLE 13 GLOBAL MARKET FOR POINT-OF-CARE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 100
TABLE 14 GLOBAL MARKET FOR IN VITRO DIAGNOSTIC TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 104
TABLE 15 GLOBAL MARKET FOR IN VITRO DIAGNOSTIC TECHNOLOGIES BY SEGMENTS, THROUGH 2021 ($ MILLIONS) 112
TABLE 16 GLOBAL MARKET FOR IMMUNOCHEMISTRY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 115
TABLE 17 GLOBAL MARKET FOR CLINICAL CHEMISTRY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 124
TABLE 18 POINT-OF-CARE DIAGNOSTIC TESTS AND MANUFACTURERS 125
TABLE 19 DIABETES INCIDENCE IN THE TOP 10 COUNTRIES, 2013 (THOUSANDS) 126
TABLE 20 GLOBAL MARKET FOR POINT-OF-CARE TESTING TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 128
TABLE 21 POINT-OF-CARE DIAGNOSTIC SOLUTIONS ACROSS PRODUCT SEGMENTS 130
TABLE 22 GLOBAL MARKET FOR MOLECULAR DIAGNOSTIC TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 132
TABLE 23 GLOBAL MARKET FOR HEMATOLOGY TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 138
TABLE 24 GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 139
TABLE 25 ABLATION TYPES AND THEIR MECHANISMS 141
TABLE 26 GLOBAL MARKET FOR CARDIOVASCULAR DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 142
TABLE 27 INCIDENCE OF RESTENOSIS BY STENT TYPE, 2014 (%) 144
TABLE 28 DRUG-ELUTING STENT PRODUCTS AND MANUFACTURERS 145
TABLE 29 BIO-ABSORBABLE STENT PRODUCTS AND MANUFACTURERS 145
TABLE 30 COMPARATIVE ANALYSIS OF STENTS BY BALLOON PLATFORM 146
TABLE 31 MANUFACTURERS AND THEIR PRODUCTS 148
TABLE 32 GLOBAL MARKET FOR CARDIAC RHYTHM MANAGEMENT TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 151
TABLE 33 ANTI-ARRHYTHMIC DRUG TYPES AND CLINICAL USAGE 154
TABLE 34 ANTI-ARRHYTHMIC DRUG CLASSIFICATION AND CLINICAL USAGE 154
TABLE 35 GLOBAL MARKET FOR CARDIAC CATHETERIZATION TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 160
TABLE 36 GLOBAL MARKET FOR ORTHOPEDIC AND SPINAL TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 164
TABLE 37 GLOBAL MARKET FOR ORTHOPEDIC AND SPINE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 165
TABLE 38 GLOBAL MARKET FOR RECONSTRUCTIVE IMPLANT TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 166
TABLE 39 GLOBAL MARKET FOR SPINE DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 174
TABLE 40 FDA AND CE APPROVALS OF SPINAL CORD STIMULATION DEVICES, 2001-2015 177
TABLE 41 GLOBAL MARKET FOR TRAUMA FIXATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 179
TABLE 42 GLOBAL MARKET FOR ROBOTIC SYSTEM TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 181
TABLE 43 GLOBAL MARKET FOR UROLOGY AND RENAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 184
TABLE 44 GLOBAL MARKET FOR UROLOGY AND RENAL DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 185
TABLE 45 GLOBAL MARKET FOR LITHOTRIPTER DEVICES BY REGION, THROUGH 2021 ($ MILLIONS) 186
TABLE 46 GLOBAL MARKET FOR INCONTINENCE DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 190
TABLE 47 GLOBAL MARKET FOR RENAL DIALYSIS DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 193
TABLE 48 GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 195
TABLE 49 GLOBAL MARKET FOR ENDOSCOPY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 196
TABLE 50 GLOBAL MARKET FOR RIGID ENDOSCOPIC DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 198
TABLE 51 GLOBAL MARKET FOR FLEXIBLE ENDOSCOPIC DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 201
TABLE 52 GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 203
TABLE 53 GLOBAL MARKET FOR DRUG DELIVERY DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 203
TABLE 54 GLOBAL MARKET FOR INFUSION SYSTEM AND INJEC
TABLE DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 207
TABLE 55 GLOBAL MARKET FOR INHALATION DEVICE TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 210
TABLE 56 GLOBAL MARKET FOR NEEDLE-FREE INJECTION AND TRANSDERMAL SYSTEM TECHNOLOGIES BY REGION, THROUGH 2021 ($ MILLIONS) 214
TABLE 57 MAJOR DRUGS ADMINISTERED THROUGH TRANSDERMAL DRUG DELIVERY TECHNIQUES 216
TABLE 58 NORTH AMERICAN MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 219
TABLE 59 EUROPEAN MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 220
TABLE 60 ASIA-PACIFIC MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 221
TABLE 61 REST OF THE WORLD MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY SEGMENT, THROUGH 2021 ($ MILLIONS) 223
TABLE 62 PRODUCT LAUNCHES AND APPROVALS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016 225
TABLE 63 MERGERS AND ACQUISITIONS IN THE MEDICAL DEVICE TECHNOLOGIES MARKET, JANUARY 2013-SEPTEMBER 2016 233
TABLE 64 AGREEMENTS, JOINT VENTURES, EXPANSIONS, DIVESTMENTS AND INVESTMENTS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016 240
TABLE 65 CERTIFICATION, REORGANIZATION, RESEARCH AND DEVELOPMENT FACILITIES, AND SERVICES AND SOLUTIONS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016 248
TABLE 66 CERTIFICATIONS AND SERVICES IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016 256
TABLE 67 REORGANIZATION, COLLABORATION, SPINOFFS, RESEARCH AND DEVELOPMENT AND APPROVALS IN THE MEDICAL DEVICE TECHNOLOGY MARKET, JANUARY 2013-SEPTEMBER 2016 257
TABLE 68 3M PRODUCT PORTFOLIO 260
TABLE 69 3M DEVELOPMENTS, JANUARY 2013-APRIL 2016 261
TABLE 70 ABBOTT LABORATORIES PRODUCT PORTFOLIO 261
TABLE 71 ABBOTT LABORATORIES DEVELOPMENTS, JANUARY 2013-APRIL 2016 262
TABLE 72 AGILENT PRODUCT PORTFOLIO 262
TABLE 73 AGILENT DEVELOPMENTS, JANUARY 2013-APRIL 2016 263
TABLE 74 BAYER HEALTHCARE PRODUCT PORTFOLIO 264
TABLE 75 BAYER HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016 264
TABLE 76 BAXTER INTERNATIONAL PRODUCT PORTFOLIO 265
TABLE 77 BAXTER INTERNATIONAL DEVELOPMENTS, JANUARY 2013-APRIL 2016 265
TABLE 78 BECKTON, DICKINSON AND COMPANY PRODUCT PORTFOLIO 266
TABLE 79 BECKTON, DICKINSON AND COMPANY DEVELOPMENTS, JANUARY 2013-APRIL 2016 266
TABLE 80 BOSTON SCIENTIFIC PRODUCT PORTFOLIO 268
TABLE 81 BOSTON SCIENTIFIC DEVELOPMENTS, JANUARY 2013-APRIL 2016 268
TABLE 82 CARDINAL HEALTH PRODUCT PORTFOLIO 269
TABLE 83 CARDINAL HEALTH DEVELOPMENTS, JANUARY 2013-APRIL 2016 270
TABLE 84 COVIDIEN PRODUCT PORTFOLIO 271
TABLE 85 COVIDIEN DEVELOPMENTS, JANUARY 2013-APRIL 2016 271
TABLE 86 DANAHER PRODUCT PORTFOLIO 272
TABLE 87 DANAHER DEVELOPMENTS, JANUARY 2013-APRIL 2016 273
TABLE 88 DRÄGER PRODUCT PORTFOLIO 274
TABLE 89 DRÄGER DEVELOPMENTS, JANUARY 2013-APRIL 2016 274
TABLE 90 FRESENIUS PRODUCT PORTFOLIO 275
TABLE 91 FRESENIUS DEVELOPMENTS, JANUARY 2013-APRIL 2016 276
TABLE 92 GE HEALTHCARE PRODUCT PORTFOLIO 277
TABLE 93 GE HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016 277
TABLE 94 GETINGE AB PRODUCT PORTFOLIO 280
TABLE 95 GETINGE AB DEVELOPMENTS, JANUARY 2013-APRIL 2016 280
TABLE 96 HALYARD HEALTH, INC. PRODUCT PORTFOLIO 281
TABLE 97 KIMBERLY-CLARK HEALTHCARE DEVELOPMENTS, JANUARY 2013-SEPTEMBER 2016 281
TABLE 98 HOSPIRA PRODUCT PORTFOLIO 282
TABLE 99 HOSPIRA DEVELOPMENTS, JANUARY 2013-APRIL 2016 283
TABLE 100 JOHNSON & JOHNSON PRODUCT PORTFOLIO 283
TABLE 101 JOHNSON & JOHNSON DEVELOPMENTS, JANUARY 2013-APRIL 2016 284
TABLE 102 MEDTRONIC PRODUCT PORTFOLIO 286
TABLE 103 MEDTRONIC RECENT DEVELOPMENTS, JANUARY 2013-APRIL 2016 286
TABLE 104 NOVARTIS PRODUCT PORTFOLIO 288
TABLE 105 NOVARTIS DEVELOPMENTS, JANUARY 2013-APRIL 2016 288
TABLE 106 OLYMPUS CORP. PRODUCT PORTFOLIO 289
TABLE 107 OLYMPUS CORP. DEVELOPMENTS, JANUARY 2013-APRIL 2016 290
TABLE 108 PALL CORP. PRODUCT PORTFOLIO 291
TABLE 109 PALL CORP. DEVELOPMENTS, JANUARY 2013-APRIL 2016 291
TABLE 110 PHILIPS PRODUCT PORTFOLIO 292
TABLE 111 PHILIPS DEVELOPMENTS, JANUARY 2013-APRIL 2016 293
TABLE 112 ROCHE DIAGNOSTICS PRODUCT PORTFOLIO 294
TABLE 113 ROCHE DIAGNOSTICS DEVELOPMENTS, JANUARY 2013-APRIL 2016 295
TABLE 114 SAINT JUDE MEDICAL PRODUCT PORTFOLIO 296
TABLE 115 SAINT JUDE MEDICAL DEVELOPMENTS, JANUARY 2013-APRIL 2016 296
TABLE 116 SIEMENS HEALTHCARE PRODUCT PORTFOLIO 297
TABLE 117 SIEMENS HEALTHCARE DEVELOPMENTS, JANUARY 2013-APRIL 2016 297
TABLE 118 SMITH & NEPHEW PRODUCT PORTFOLIO 299
TABLE 119 SMITH & NEPHEW DEVELOPMENTS, JANUARY 2013-APRIL 2016 299
TABLE 120 SMITHS MEDICAL PRODUCT PORTFOLIO 300
TABLE 121 SMITHS MEDICAL DEVELOPMENTS, JANUARY 2013-APRIL 2016 301
TABLE 122 STRYKER CORP. PRODUCT PORTFOLIO 302
TABLE 123 STRYKER CORP. DEVELOPMENTS, 2013-APRIL 2016 303
TABLE 124 SYNTHES PRODUCT PORTFOLIO 304
TABLE 125 TELEFLEX PRODUCT PORTFOLIO 305
TABLE 126 TELEFLEX DEVELOPMENTS, JANUARY 2013-APRIL 2016 305
TABLE 127 THERMO FISHER SCIENTIFIC PRODUCT PORTFOLIO 307
TABLE 128 THERMO FISHER SCIENTIFIC DEVELOPMENTS, JANUARY 2013-APRIL 2016 307
TABLE 129 TOSHIBA MEDICAL SYSTEMS PRODUCT PORTFOLIO 309
TABLE 130 TOSHIBA MEDICAL SYSTEMS DEVELOPMENTS, JANUARY 2013-APRIL 2016 309
TABLE 131 ZIMMER HOLDINGS PRODUCT PORTFOLIO 310
TABLE 132 ZIMMER HOLDINGS DEVELOPMENTS, JANUARY 2013-FEBRUARY 2016 310
TABLE 133 U.S. MEDICAL DEVICE TECHNOLOGY PATENTS, 2011-APRIL 2016 313
TABLE 134 EUROPEAN MEDICAL DEVICE TECHNOLGY PATENTS, 2011-APRIL 2016 316
TABLE 135 JAPANESE MEDICAL DEVICE TECHNOLOGY PATENTS, 2011-APRIL 2016 322


LIST OF FIGURES
SUMMARY FIGURE GLOBAL MARKET FOR MEDICAL DEVICE TECHNOLOGIES BY REGION, 2015-2021 ($ MILLIONS) 7
FIGURE 1 GLOBAL POPULATION OLDER THAN AGE 60 BY REGION, 2013 30
Country=World Industry=MedicalDevice ParentIndustry=Healthcare Date=201701 Topic=MarketReport Publisher=BCCResearch Price=5000